-+ 0.00%
-+ 0.00%
-+ 0.00%

ADDEX THERAPEUTICS - NEUROSTERIX COMPLETES PHASE 1 STUDIES OF NTX-253, PLANS PHASE 2 DEVELOPMENT

Reuters·10/08/2026 05:03:30